L

Laurus Labs Ltd

PharmaceuticalsLargecap

About the company

Laurus Labs Private Ltd is a research and development pharmaceutical company which manufactures active pharmaceutical ingredients (APIs) for anti-retroviral (ARV) and Hepatitis C. It also manufactures APIs in oncology and other therapeutic areas.

Performance

Stock
Loading Stock value
—

Analyst Ratings and Key Metrics

Based on 12 analysts offering recommendations for Laurus Labs Ltd

58%

Buy

25%

Hold

17%

Sell

Key MetricsThis StockCategory (Avg)
PE Ratio124.6245.85
PB Ratio20.395.74
Dividend Yield0.10%0.50%

Understand what these metrics mean. 

Equity investments are subject to market risks. Read all the related documents carefully before investing. By using this page, you agree to the Terms & Conditions